-
Molecular and cellular consequences of mevalonate kinase deficiency
Politiek, F. A., Turkenburg, M., Henneman, L., Ofman, R. & Waterham, H. R., 1 Jun 2024, In: Biochimica et Biophysica Acta - Molecular Basis of Disease. 1870, 5, 167177.Research output: Contribution to journal › Article › Academic › peer-review
-
Mevalonate kinase-deficient THP-1 cells show a disease-characteristic pro-inflammatory phenotype
Politiek, F. A., Turkenburg, M., Ofman, R. & Waterham, H. R., 2024, In: Frontiers in immunology. 15, 1379220.Research output: Contribution to journal › Article › Academic › peer-review
-
Identification of FDA-approved drugs that increase mevalonate kinase in hyper IgD syndrome
Politiek, F. A., Turkenburg, M., Koster, J., Ofman, R. & Waterham, H. R., 2023, (E-pub ahead of print) In: Journal of inherited metabolic disease.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
